Analysts say Embecta is ‘heading in the right direction’
Analysts called a stock sell-off at Embecta “unwarranted” and believe the company is moving in the right direction despite recent challenges.
Analysts called a stock sell-off at Embecta “unwarranted” and believe the company is moving in the right direction despite recent challenges.
Cleveland Clinic research has identified immunologic factors associated with recurrence in patients with recurrent/metastatic oropharyngeal cancer.
Unlock the future of business negotiations with Kaspar, the visionary co-founder of Pactum, as he shares his groundbreaking journey from pioneering Estonia’s e-residency to revolutionizing…
The pandemic emergency offered fresh opportunities to ramp up use of teamwork, tech to deepen learning and help patients, says recent study.
The tech world faced rapid developments in AI systems, so that LLMs were nicknamed “human assistants” in many industries. Your new mentor!
For the first time, the Alcohol and Tobacco Tax and Trade Bureau proposed rules that would bring alcohol labels closer in line with food packaging.
Tech giants like Meta and YouTube want to poach TikTokers, with Snapchat, X, Substack and others also planning efforts to coax them to their platforms.
In this analysis, the investigators sought to assess the ability of a ChatGPT-4-based chatbot in its performance of key functions in a teledermatology platform.
Most people who take statins don’t experience muscle aches, but if you do, it’s important to know that you have options. An interventional cardiologist explains…
Gary Guthart gave a glimpse of surgeons’ initial response to the new robot at the J.P. Morgan Healthcare Conference.
Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and considered life-saving.